TY - JOUR
T1 - Barriers to and enablers of type 2 diabetes screening among women with prior gestational diabetes
T2 - A qualitative study applying the Theoretical Domains Framework
AU - Lake, Amelia J.
AU - Williams, Amelia
AU - Neven, Adriana C.H.
AU - Boyle, Jacqueline A.
AU - Dunbar, James A.
AU - Hendrieckx, Christel
AU - Morrison, Melinda
AU - O’Reilly, Sharleen L.
AU - Teede, Helena
AU - Speight, Jane
AU - on behalf of the ME-MaGDA study group
N1 - Funding Information:
This project was funded by the Australian Government Department of Health (Health/18/1904983). CH and JS are supported by the core funding to the Australian Centre for Behavioral Research in Diabetes provided by the collaboration between Diabetes Victoria and Deakin University. HT is supported by an NHMRC fellowship. Acknowledgments
Publisher Copyright:
Copyright © 2023 Lake, Williams, Neven, Boyle, Dunbar, Hendrieckx, Morrison, O’Reilly, Teede and Speight.
PY - 2023
Y1 - 2023
N2 - Introduction: Women with previous gestational diabetes mellitus (GDM) are at increased risk of type 2 diabetes (T2D). Guidelines recommend postnatal diabetes screening (oral glucose tolerance test or HbA1c) typically 6-12 weeks after birth, with screening maintained at regular intervals thereafter. Despite this, around half of women are not screened, representing a critical missed opportunity for early identification of prediabetes or type 2 diabetes. While policy and practice-level recommendations are comprehensive, those at the personal-level primarily focus on increasing screening knowledge and risk perception, potentially missing other influential behavioral determinants. We aimed to identify modifiable, personal-level factors impacting postpartum type 2 diabetes screening among Australian women with prior gestational diabetes and recommend intervention functions and behavior change techniques to underpin intervention content. Research design and methods: Semi-structured interviews with participants recruited via Australia’s National Gestational Diabetes Register, using a guide based on the Theoretical Domains Framework (TDF). Using an inductive-deductive approach, we coded data to TDF domains. We used established criteria to identify ‘important’ domains which we then mapped to the Capability, Opportunity, Motivation–Behavior (COM-B) model. Results: Nineteen women participated: 34 ± 4 years, 19 ± 4 months postpartum, 63% Australian-born, 90% metropolitan, 58% screened for T2D according to guidelines. Eight TDF domains were identified: ‘knowledge’, ‘memory, attention, and decision-making processes’, ‘environmental context and resources’, ‘social influences’, ‘emotion’, ‘beliefs about consequences’, ‘social role and identity’, and ‘beliefs about capabilities’. Study strengths include a methodologically rigorous design; limitations include low recruitment and homogenous sample. Conclusions: This study identified numerous modifiable barriers and enablers to postpartum T2D screening for women with prior GDM. By mapping to the COM-B, we identified intervention functions and behavior change techniques to underpin intervention content. These findings provide a valuable evidence base for developing messaging and interventions that target the behavioral determinants most likely to optimize T2D screening uptake among women with prior GDM.
AB - Introduction: Women with previous gestational diabetes mellitus (GDM) are at increased risk of type 2 diabetes (T2D). Guidelines recommend postnatal diabetes screening (oral glucose tolerance test or HbA1c) typically 6-12 weeks after birth, with screening maintained at regular intervals thereafter. Despite this, around half of women are not screened, representing a critical missed opportunity for early identification of prediabetes or type 2 diabetes. While policy and practice-level recommendations are comprehensive, those at the personal-level primarily focus on increasing screening knowledge and risk perception, potentially missing other influential behavioral determinants. We aimed to identify modifiable, personal-level factors impacting postpartum type 2 diabetes screening among Australian women with prior gestational diabetes and recommend intervention functions and behavior change techniques to underpin intervention content. Research design and methods: Semi-structured interviews with participants recruited via Australia’s National Gestational Diabetes Register, using a guide based on the Theoretical Domains Framework (TDF). Using an inductive-deductive approach, we coded data to TDF domains. We used established criteria to identify ‘important’ domains which we then mapped to the Capability, Opportunity, Motivation–Behavior (COM-B) model. Results: Nineteen women participated: 34 ± 4 years, 19 ± 4 months postpartum, 63% Australian-born, 90% metropolitan, 58% screened for T2D according to guidelines. Eight TDF domains were identified: ‘knowledge’, ‘memory, attention, and decision-making processes’, ‘environmental context and resources’, ‘social influences’, ‘emotion’, ‘beliefs about consequences’, ‘social role and identity’, and ‘beliefs about capabilities’. Study strengths include a methodologically rigorous design; limitations include low recruitment and homogenous sample. Conclusions: This study identified numerous modifiable barriers and enablers to postpartum T2D screening for women with prior GDM. By mapping to the COM-B, we identified intervention functions and behavior change techniques to underpin intervention content. These findings provide a valuable evidence base for developing messaging and interventions that target the behavioral determinants most likely to optimize T2D screening uptake among women with prior GDM.
KW - behavior therapy
KW - female
KW - gestational diabetes
KW - glucose tolerance test
KW - persuasive communication
KW - postpartum period
KW - qualitative
KW - type 2 diabetes mellitus
UR - http://www.scopus.com/inward/record.url?scp=85168773679&partnerID=8YFLogxK
U2 - 10.3389/fcdhc.2023.1086186
DO - 10.3389/fcdhc.2023.1086186
M3 - Article
C2 - 36993822
AN - SCOPUS:85168773679
SN - 2673-6616
VL - 4
JO - Frontiers in Clinical Diabetes and Healthcare
JF - Frontiers in Clinical Diabetes and Healthcare
M1 - 1086186
ER -